Literature DB >> 33758570

Structure insights of SARS-CoV-2 open state envelope protein and inhibiting through active phytochemical of ayurvedic medicinal plants from Withania somnifera.

Raed Abdullah Alharbi1.   

Abstract

Coronaviruses have beeene">n causiene">ng pandemic situations across the globe for the past two decades and the focus is on identifying suitable novel targets for antivirals and vaccine development. SARS-CoV-2 encodes a small hydrophobic envelope (E) protein that mediates envelope formation, budding, replication, and release of progeny viruses from the host. Through this study, the SARS-CoV-2 E protein is studied for its open and closed state and focused in identifying antiviral herbs used in traditional medicine practices for COVID-19 infections. In this study using computational tools, we docked the shortlisted phytochemicals with the envelope protein of the SARS-CoV-2 virus and the results hint that these compounds interact with the pore-lining residues. The molecular level understanding of the open state is considered and the active inhibitors from the phytochemicals of Ayurvedic medicinal plants from Withania somnifera. We have thus identified a potential phytochemical compound that directly binds with the pore region of the E protein and thereby blocks its channel activity. Blocking the ion channel activity of E protein is directly related to the inhibition of virus replication. The study shows encouraging results on the usage of these phytochemicals in the treatment/management of SARS-CoV-2 infection.
© 2021 The Author(s).

Entities:  

Keywords:  Bioinformatics; Protein; Protein Informatics; Public Health; SARS-CoV-2; Withania somnifera

Year:  2021        PMID: 33758570      PMCID: PMC7970802          DOI: 10.1016/j.sjbs.2021.03.036

Source DB:  PubMed          Journal:  Saudi J Biol Sci        ISSN: 2213-7106            Impact factor:   4.219


  32 in total

1.  Structure-Based Virtual Screening and Biological Evaluation of a Calpain Inhibitor for Prevention of Selenite-Induced Cataractogenesis in an in Vitro System.

Authors:  Arumugam Ramachandran Muralidharan; Chandrabose Selvaraj; Sanjeev Kumar Singh; Joen-Rong Sheu; Philip A Thomas; Pitchairaj Geraldine
Journal:  J Chem Inf Model       Date:  2015-08-13       Impact factor: 4.956

2.  Exploration of protein-protein interaction effects on α-2-macroglobulin in an inhibition of serine protease through gene expression and molecular simulations studies.

Authors:  Jeyachandran Sivakamavalli; Chandrabose Selvaraj; Sanjeev Kumar Singh; Baskaralingam Vaseeharan
Journal:  J Biomol Struct Dyn       Date:  2013-10-14

3.  The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.

Authors:  Susanne Pfefferle; Julia Schöpf; Manfred Kögl; Caroline C Friedel; Marcel A Müller; Javier Carbajo-Lozoya; Thorsten Stellberger; Ekatarina von Dall'Armi; Petra Herzog; Stefan Kallies; Daniela Niemeyer; Vanessa Ditt; Thomas Kuri; Roland Züst; Ksenia Pumpor; Rolf Hilgenfeld; Frank Schwarz; Ralf Zimmer; Imke Steffen; Friedemann Weber; Volker Thiel; Georg Herrler; Heinz-Jürgen Thiel; Christel Schwegmann-Wessels; Stefan Pöhlmann; Jürgen Haas; Christian Drosten; Albrecht von Brunn
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

4.  Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.

Authors:  Chandrabose Selvaraj; Dhurvas Chandrasekaran Dinesh; Umesh Panwar; Rajaram Abhirami; Evzen Boura; Sanjeev Kumar Singh
Journal:  J Biomol Struct Dyn       Date:  2020-06-22

Review 5.  Coronavirus membrane fusion mechanism offers a potential target for antiviral development.

Authors:  Tiffany Tang; Miya Bidon; Javier A Jaimes; Gary R Whittaker; Susan Daniel
Journal:  Antiviral Res       Date:  2020-04-06       Impact factor: 5.970

6.  Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?

Authors:  Martina Bianchi; Domenico Benvenuto; Marta Giovanetti; Silvia Angeletti; Massimo Ciccozzi; Stefano Pascarella
Journal:  Biomed Res Int       Date:  2020-05-30       Impact factor: 3.411

7.  Tailor-made multiple sequence alignments using the PRALINE 2 alignment toolkit.

Authors:  Maurits J J Dijkstra; Atze J van der Ploeg; K Anton Feenstra; Wan J Fokkink; Sanne Abeln; Jaap Heringa
Journal:  Bioinformatics       Date:  2019-12-15       Impact factor: 6.937

8.  Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease.

Authors:  Chandrabose Selvaraj; Umesh Panwar; Dhurvas Chandrasekaran Dinesh; Evzen Boura; Poonam Singh; Vikash Kumar Dubey; Sanjeev Kumar Singh
Journal:  Front Chem       Date:  2021-01-13       Impact factor: 5.221

Review 9.  Middle East Respiratory Syndrome Coronavirus (MERS-CoV): a perpetual challenge.

Authors:  Sami Al Hajjar; Ziad A Memish; Kenneth McIntosh
Journal:  Ann Saudi Med       Date:  2013 Sep-Oct       Impact factor: 1.526

Review 10.  Viroporins and inflammasomes: A key to understand virus-induced inflammation.

Authors:  N S Farag; U Breitinger; H G Breitinger; M A El Azizi
Journal:  Int J Biochem Cell Biol       Date:  2020-03-07       Impact factor: 5.085

View more
  2 in total

Review 1.  Multifaceted roles of plant derived small molecule inhibitors on replication cycle of SARS-CoV-2.

Authors:  B Uma Reddy; Nanda Kishore Routhu; Anuj Kumar
Journal:  Microb Pathog       Date:  2022-04-02       Impact factor: 3.848

2.  The Flexible, Extended Coil of the PDZ-Binding Motif of the Three Deadly Human Coronavirus E Proteins Plays a Role in Pathogenicity.

Authors:  Dewald Schoeman; Ruben Cloete; Burtram C Fielding
Journal:  Viruses       Date:  2022-08-02       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.